Antibiotic use and cost its in nosocomial Pneumonia infection: Evidence from Intensive care units of a large hospital

Document Type : Research Paper

Authors

1 MSc in Health Economics, Department of Health Economics and Management Sciences, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran

2 Associate Professor, Department of Health Economics and Management Sciences, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran (Corresponding author)

3 Associate Professor, Department of Biostatistics and epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.

4 Associate Professor, Department of Infectious Diseases, School of Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran

5 Assistant Professor, Department of Pediatrics, School of Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran

6 Bachelor of Nursing, Infection Prevention and Control Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Introduction: Pneumonia is one of the most common nosocomial infections in intensive care units.  In the treatment of healthcare-related infections, antibiotics account for a significant portion of the cost of medication in the intensive care unit (ICU).The aim of this study was to investigate the changes in antibiotic use in terms of frequency and cost of nosocomial infection in ICU at Imam Reza 1000 Bed Referal Hospital in Mashhad.
Methods: The present study is a descriptive and cross-sectional on the records of hospitalized patients with nosocomial pneumonia in Internal and Surgical ICU in Imam Reza hospital in 2016. The population was surveyed in full.  Refer to patient records, identify antibiotics consumed Based on the prescribed dose for all patients studied, separation was confirmed for each hospitalization day. Then calculations were performed for the mean frequency of each drug item and its cost per day for one patient for the periods before, during and after pneumonia.
Results: The results showed that the average cost of antibiotics per day for each patient during the period of nosocomial infection was 538431 million Rials and 343979 million Rials in the previous period. That is a 57 percent increase compared to the pre-pneumonia period. There was also a 33 percent increase in the incidence of pneumonia during the period.
Conclusion: Over 50% increase in the volume of prescribed antibiotics during pneumonia nosocomial infection is important both in terms of health care costs and microbial resistance. The findings of the present study can be used to evaluate strategies to reduce this infection through cost-effectiveness studies.

Keywords

References

1. Djordjevic ZM, Folic MM, Jankovic SM. Distribution and antibiotic susceptibility of pathogens isolated from
adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit. Journal of infection and public
health. 2017;10(6):740-744.
2. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International
ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated
pneumonia: Guidelines for the management of hospital-acquired pneumonia (1)/ventilator-associated pneumonia (VAP)
of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society
of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
European Respiratory Journal. 2017;50(3):1700582.
3. Chouhdari A, Shokouhi S, Bashar FR, Vahedian Azimi A, Shojaei SP, Fathi M, et al. Is a Low Incidence Rate
of Ventilation Associated Pneumonia Associated with Lower Mortality? a Descriptive Longitudinal Study in Iran.
Tanaffos. 2018;17(2):110-116.
4. Misal DD, Maulingkar SV, Bhonsle S. Economic burden of antibiotic treatment of healthcare-associated
infections at a tertiary care hospital ICU in Goa, India. Tropical doctor. 2017;47(3):197-201.
5. Tiwari P, Rohit M. Assessment of costs associated with hospital-acquired infections in a private tertiary care
hospital in India. Value in Health regional issues. 2013;2(1):87-91.
6. Karkhane M, Pourhosiengholi MA, Torkabad MRA, Kimiia Z, Mortazavi SM, Aghdam SKH, et al. Annual
antibiotic related economic burden of healthcare associated infections; a cross-sectional population based study. Iranian
journal of pharmaceutical research: IJPR. 2016;15(2):605 -610.
7. Alp E, Kalin G ,Coskun R, Sungur M, Guven M, Doganay M. Economic burden of ventilator-associated
pneumonia in a developing country. The Journal of hospital infection. 2012;81(2):128-130.
8. Morillo-García Á, Aldana-Espinal JM, de Labry-Lima AO, Valencia-Martín R, López-Márquez R, LoscertalesAbril M, et al. Hospital costs associated with nosocomial infections in a pediatric intensive care unit. Gaceta sanitaria.
2015;29(4):282-287.
9. Khan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance.
Asian Pacific Journal of Tropical Biomedicine. 2017;7(5):478-482.
medical journal of mashhad university of medical sciences
Volume 63, Issue 6
January and February 2021
Pages 1983-1989

Files

Share

How to cite

Statistics